Thiopentone

Thiopentone


THIOPENTONE

  • Ultrashort-acting thiobarbiturate.
  • Used in induction of anaesthesia due to rapid onset of action.
  • Very alkaline solution.
  • Must be prepared freshly before injection.
  • Highly soluble in water.
  • Supplied as powder containing sodium salts with 6% sodium carbonate.
  • Sodium carbonate is for water solubility.

PHARMACOKINETICS: 

  • Un-dissociated form is highly lipid soluble contributes to, 
  • Very rapid redistribution.
  • Instant entry into the brain.
  • Very short duration of action.
  • Quick termination of drug action.

DOSE:

  • Given intravenously.
  • Typical induction dose: 3-5 mg/kg /2.5%.
  • Produces unconsciousness in 10-30 seconds.
  • Peak effect in 1 min.
  • Duration of anaesthesia: 5-8 minutes.

ACTION:

C.N.S:

  • General anaesthesia.
  • Reduces cerebral metabolic rate.
  • Measured by cerebral oxygen consumption (CMRO2) in dose-dependent manner.
  • Decreased CMRO2 results in reduced cerebral metabolism & subsequently cerebral blood flow & intracranial pressure.
  • Hence used as “Protectant” against cerebral ischemia.
  • Also reduces intraocular pressure.
  • Has CNS depressant activity – Effective anticonvulsants.
  • Proven medication for status epilepticus.

Respiratory:

  • Causes respiratory depressants in dose-dependent decrease in minute ventilation & tidal volume.
  • Smaller & inconsistent decrease in respiratory rate.

CVS:

  • Produces dose-dependent decrease in blood pressure.
  • Due to vasodilation, reduced ventilation & direct decrease in cardiac contractility.
  • Hypotension severe in patients with,
  • Impaired ability to compensate for ventilation.
  • Seen with hypovolemia.
  • Cardiomyopathy.
  • Valvular heart disease.
  • CAD.
  • Cardiac tamponade.
  • β-adrenergic block.

USES:

  • Narcoanalysis.
  • Reduction of ICP.
  • Head Injury.
  • Duchenne muscular dystrophy for tendon lengthening procedure.
  • RTA.
  • Seizure.

ADVERSE EFFECT:

  • On extravasation or intraarterial injection cause intense pain & even necrosis.
  • Induce fatal attacks of porphyria in patients with acute intermittent porphyria.
  • Intravenous injection produces rash, pain & spasm.

CONTRAINDICATIONS:

  • Acute intermittent porphyria.
Exam Question
 
  • Fall in intracranial tension, decreases oxygen consumption of brain & decreases metabolic rate of the brain are seen as an effect of thiopentone
  • Dose of thiopentone is 2.5% 
  • Sodium carbonate is added to improve solubility of thiopentone.
  • Thiopentone is Cerebro protective
  • Thiopentone is contraindicated in porphyria
  • Thiopentone on extravasation or intraarterial injection cause intense pain and even necrosis.
  • Thiopentone is indicated in case of head injury.
  • Thiopentone is indicated in increased intracranial tension.
  • Thiopentone does not trigger malignant hyperthermia.
  • Sodium Thiopentone is ultra short-acting due to rapid redistribution.
  • Thiopentone is commonly used in narcoanalysis.
  • Intravenous thiopentone produces rash, pain, spasm
  • Intraarterial injection of thiopentone causes vasodilation, necrosis of vessel wall, hypotension
  • Anaesthesia used in Duchenne muscular dystrophy for tendon lengthening procedure is induction with intravenous thiopentone and N20; and halothane for maintenance.
  • Thiopentone is highly distributed to body fat that is an anaesthetic agent lacking analge­sic effect.
  • Action of i. v. thiopentone is terminated by redistribution.
Don’t Forget to Solve all the previous Year Question asked on Thiopentone

Leave a Comment

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support ❌